Curt Bradshaw
Equibles does not estimate personal net worth.
Get an email with a short summary when Arrowhead Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ARWR alertsAbout Curt Bradshaw
The proxy statement of Arrowhead Pharmaceuticals, Inc. reports total compensation of $6,373,206 for Curt Bradshaw in fiscal 2020, including a base salary of $338,462. Disclosed compensation is on record for 3 fiscal years. Arrowhead Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arrowhead Pharmaceuticals, Inc. includes Christopher Anzalone (CEO and Board Member), Daniel Apel (CFO), Patrick O'Brien (COO) and 7 others.
Affiliation history
-
Arrowhead Pharmaceuticals, Inc. (ARWR)
Source not stated
Current
Company network
Leadership on record at Arrowhead Pharmaceuticals, Inc.
- Christopher Anzalone CEO, Board Member
- Daniel Apel CFO
- Patrick O'Brien COO
- Patrick O’Brien COO, General Counsel
- Douglas Ingram Board Member
- Dr. Matt Cohen, M.D., M.B.A. Board Member
- Hongbo Lu Board Member
- Hongbo Lu, Ph.D. Board Member
- Oye Olukotun, M.D., MPH Board Member
- Victoria Vakiener Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Former Chief Scientific Officer | $338,462 | $6,373,206 |
| 2019 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Former Chief Scientific Officer | — | — |
| 2018 | Arrowhead Pharmaceuticals, Inc. (ARWR) | Former Chief Scientific Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.